Holy Stone Healthcare Co., Ltd.(TW:4194)
NT$6.35+0.24 (+4.10%)
TW:4194
Holy Stone Healthcare Co., Ltd. financials statements
NT$6.35
At close:+0.24 (+4.10%)
Holy Stone Healthcare Co., Ltd. (4194) Ratios
Holy Stone Healthcare Co., Ltd. Ratios
TW:4194's free cash flow for Q2 2026 was NT$-61.80M. For the 2026 fiscal year, TW:4194's free cash flow was decreased by NT$-832.00K and operating cash flow was NT$-60.97M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.29 | 5.98 | 1.30 | 7.15 | 4.15 |
| Quick Ratio | 5.29 | 5.98 | 1.09 | 6.93 | 3.86 |
| Cash Ratio | 4.62 | 5.41 | 0.82 | 6.00 | 3.23 |
| Solvency Ratio | -2.62 | -2.91 | -2.32 | -1.47 | -2.08 |
| Operating Cash Flow Ratio | -3.50 | -2.89 | -2.65 | -1.97 | -2.30 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -4.62 | -25.06 | -1482.47 |
| Net Current Asset Value | NT$ 127.27M | NT$ 235.86M | NT$ 18.45M | NT$ 438.69M | NT$ 169.97M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.04 | 0.38 | 0.05 | 0.08 |
| Debt-to-Equity Ratio | 0.06 | 0.05 | 0.92 | 0.06 | 0.11 |
| Debt-to-Capital Ratio | 0.06 | 0.05 | 0.48 | 0.05 | 0.10 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.21 | 1.20 | 2.41 | 1.18 | 1.30 |
| Debt Service Coverage Ratio | -516.11 | -268.10 | -4.47 | -20.92 | -269.81 |
| Interest Coverage Ratio | -564.26 | -297.97 | -412.29 | -238.71 | -343.37 |
| Debt to Market Cap | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.08 | 0.11 | 0.57 | 0.25 | 0.27 |
| Net Debt to EBITDA | 1.00 | 1.48 | 0.03 | 3.24 | 1.04 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 27.67% | 41.95% | 45.62% | 46.91% |
| EBIT Margin | 0.00% | -153.94% | -119.77% | -53.96% | -80.90% |
| EBITDA Margin | 0.00% | -143.77% | -112.46% | -47.50% | -72.69% |
| Operating Profit Margin | 0.00% | -159.82% | -121.83% | -55.12% | -80.83% |
| Pretax Profit Margin | 0.00% | -154.48% | -120.07% | -54.19% | -81.14% |
| Net Profit Margin | 0.00% | -154.50% | -122.15% | -56.59% | -83.52% |
| Continuous Operations Profit Margin | 0.00% | -154.50% | -122.15% | -56.59% | -83.52% |
| Net Income Per EBT | 100.02% | 100.01% | 101.74% | 104.44% | 102.93% |
| EBT Per EBIT | 76.47% | 96.66% | 98.55% | 98.31% | 100.39% |
| Return on Assets (ROA) | -50.49% | -51.98% | -144.26% | -24.88% | -52.91% |
| Return on Equity (ROE) | -60.90% | -62.40% | -347.10% | -29.26% | -68.66% |
| Return on Capital Employed (ROCE) | -76.89% | -62.50% | -300.39% | -27.56% | -62.06% |
| Return on Invested Capital (ROIC) | -75.13% | -61.54% | -179.95% | -26.99% | -59.91% |
| Return on Tangible Assets | -50.49% | -51.98% | -144.29% | -25.11% | -54.09% |
| Earnings Yield | -9.87% | -10.00% | -11.12% | -4.16% | -5.71% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 9.82 | 86.30 | 5.89 | 12.74 |
| Payables Turnover | 0.00 | 438.30 | 0.00 | 7.96 | 13.85 |
| Inventory Turnover | 0.00 | 309.01 | 6.39 | 9.08 | 6.79 |
| Fixed Asset Turnover | 0.00 | 2.12 | 3.77 | 3.76 | 2.68 |
| Asset Turnover | 0.00 | 0.34 | 1.18 | 0.44 | 0.63 |
| Working Capital Turnover Ratio | 0.00 | 0.86 | 0.97 | 0.84 | 0.77 |
| Cash Conversion Cycle | 0.00 | 37.53 | 61.37 | 56.33 | 56.06 |
| Days of Sales Outstanding | 0.00 | 37.19 | 4.23 | 61.97 | 28.65 |
| Days of Inventory Outstanding | 0.00 | 1.18 | 57.14 | 40.20 | 53.77 |
| Days of Payables Outstanding | 0.00 | 0.83 | 0.00 | 45.84 | 26.35 |
| Operating Cycle | 0.00 | 38.37 | 61.37 | 102.17 | 82.42 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.74 | -1.01 | -2.03 | -1.21 | -1.25 |
| Free Cash Flow Per Share | -0.79 | -1.02 | -2.06 | -1.23 | -1.29 |
| Dividend Paid and CapEx Coverage Ratio | -15.01 | -67.93 | -78.55 | -67.91 | -32.17 |
| Capital Expenditure Coverage Ratio | -15.01 | -67.93 | -78.55 | -67.91 | -32.17 |
| Operating Cash Flow Coverage Ratio | -9.98 | -9.93 | -3.60 | -5.02 | -4.78 |
| Operating Cash Flow to Sales Ratio | 0.00 | -1.20 | -1.17 | -0.54 | -0.64 |
| Free Cash Flow Yield | -10.32% | -7.88% | -10.79% | -4.03% | -4.48% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -10.13 | -10.04 | -9.00 | -24.07 | -17.50 |
| Price-to-Sales (P/S) Ratio | 0.00 | 15.46 | 10.99 | 13.61 | 14.63 |
| Price-to-Book (P/B) Ratio | 6.17 | 6.24 | 31.22 | 7.03 | 12.03 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -9.69 | -12.68 | -9.27 | -24.83 | -22.34 |
| Price-to-Operating Cash Flow Ratio | -10.34 | -12.87 | -9.39 | -25.20 | -23.03 |
| Price-to-Earnings Growth (PEG) Ratio | 0.25 | 0.26 | -0.13 | 1.05 | -0.43 |
| Enterprise Value Multiple | -7.47 | -9.27 | -9.74 | -25.40 | -19.08 |
| Enterprise Value | 994.93M | 1.58B | 2.59B | 3.26B | 3.01B |
| EV to EBITDA | -7.47 | -9.27 | -9.74 | -25.40 | -19.08 |
| EV to Sales | 0.00 | 13.33 | 10.95 | 12.07 | 13.87 |
| EV to Free Cash Flow | -8.55 | -10.94 | -9.24 | -22.02 | -21.18 |
| EV to Operating Cash Flow | -9.12 | -11.10 | -9.36 | -22.35 | -21.84 |
| Tangible Book Value Per Share | 1.25 | 2.07 | 0.61 | 4.30 | 2.33 |
| Shareholders’ Equity Per Share | 1.25 | 2.07 | 0.61 | 4.35 | 2.40 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.02 | -0.04 | -0.03 |
| Revenue Per Share | 0.00 | 0.84 | 1.74 | 2.25 | 1.97 |
| Net Income Per Share | -0.76 | -1.29 | -2.12 | -1.27 | -1.65 |
| Tax Burden | 1.00 | 1.00 | 1.02 | 1.04 | 1.03 |
| Interest Burden | 0.76 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 1.47 | 1.26 | 0.66 | 0.86 |
| SG&A to Revenue | 0.00 | 0.41 | 0.38 | 0.35 | 0.33 |
| Stock-Based Compensation to Revenue | 0.00 | 0.02 | 0.01 | 0.01 | 0.00 |
| Income Quality | 0.98 | 0.78 | 0.96 | 1.00 | 0.78 |
Currency in TWD
